Profiles of malignant GCTs and potential biomarkers for CNS germ cell tumours

State of CNS germ cell tumour research in North America

Classification and immunohistochemical approach of intracranial germ cell tumours

Advances and perspectives on biomarkers

Biomarker analyses in emerging data from PI3K/AKT/mTOR programme clinical trials

Integrating breast cancer genomics and proteomics

Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer

Breast cancer heterogeneity no barrier to predictive testing

Single cell sequencing techniques in early and late breast cancer

Measurement variation influences gene expression profiles of breast cancer

The future of PI3K/AKT/mTOR inhibitors in breast cancer

Multitarget FISH testing in lung cancer